Home
PHAR

PHAR

Pharming Group N.V.

as of 12-15-2025 11:07am EST

$16.88

$0.99

-5.54%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Chart Type:

Time Range:

Founded:	1988	Country:	Netherlands
Employees:	N/A	City:	N/A
Market Cap:	1.1B	IPO Year:	N/A
Target Price:	$30.00	AVG Volume (30 days):	21.0K
Analyst Decision:	Strong Buy	Number of Analysts:	3
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	0.00	EPS Growth:	N/A
52 Week Low/High:	$7.50 - $18.12	Next Earning Date:	11-06-2025
Revenue:	$362,274,000	Revenue Growth:	26.78%
Revenue Growth (this year):	24.8%	Revenue Growth (next year):	6.84%

AI-Powered PHAR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 65.94%

65.94%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full PHAR Forecast & Prediction with Hourly Data

Compare PHAR vs Leading Stocks

See how PHAR stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free PHAR Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "PHAR Pharming Group N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.